Bleakley Financial Group’s MaxLinear MXL Stock Holding History

Bleakley Financial Group’s Portfolio MXL Stock Details MXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-42,735	Closed	-$951K	–	965
2023 Q3	$951K	Buy	+42,735	New	+$1.09M	0.03%	388

Other funds holding MXL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bleakley Financial Group's MXL Position: Q4 2023 in Review

Bleakley Financial Group sold out of MaxLinear (MXL) in Q4 2023, closing a stake of 42,735 shares — an estimated $951K sold.

Bleakley Financial Group first reported a position in MXL in Q3 2023 and held it in 1 quarter. The position peaked at $951K in Q3 2023. 213 funds tracked by Wall St. Rank hold MXL as of Q4 2023.

Bleakley Financial Group reported no remaining MaxLinear position as of Q4 2023 after selling out during the quarter.
Bleakley Financial Group sold 42,735 MaxLinear shares in Q4 2023, an estimated $951K.
Bleakley Financial Group first reported a position in MaxLinear in Q3 2023 and held it in 1 quarter.
Bleakley Financial Group's MaxLinear position peaked at $951K in Q3 2023.
213 funds tracked by Wall St. Rank held MaxLinear as of Q4 2023.

Based on Bleakley Financial Group's 13F filing for Q4 2023, filed 25 Jan 2024.